Fibrogen Stock Ownership - Who Owns Fibrogen in 2024?

Fibrogen (NASDAQ: FGEN) is owned by 45.58% institutional shareholders, 12.31% Fibrogen insiders, and 42.10% retail investors. Astellas Pharma Inc is the largest individual Fibrogen shareholder, owning 4.97M shares representing 4.93% of the company. Astellas Pharma Inc's …

58%
OFF

Fibrogen Stock Ownership - Who Owns Fibrogen In 2024?

2 weeks from now

wallstreetzen.com

$55
OFF

FibroGen, Inc. Insider Trading & Ownership Structure - Simply Wall …

2 weeks from now

Uncover the latest insider trading activity for FibroGen, Inc. (FGEN). ... FibroGen, Inc. NasdaqGS:FGEN Stock Report. Market Cap: US$55.0m. Add to watchlist. Company …

simplywall.st

73%
OFF

With 73% Ownership In FibroGen, Inc. (NASDAQ:FGEN), …

2 weeks from now

Jan 16, 2023 · A look at the shareholders of FibroGen, Inc. ( NASDAQ:FGEN ) can tell us which group is most powerful. With 73% stake...

yahoo.com

1%
OFF

Geode Capital Management LLC Boosts Stock Position In …

2 weeks from now

3 days ago · Geode Capital Management LLC raised its holdings in shares of FibroGen, Inc. (NASDAQ:FGEN – Free Report) by 3.1% in the 3rd quarter, according to the company in its …

etfdailynews.com

$0.17
OFF

FibroGen (FGEN) Earnings Date And Reports 2025 - MarketBeat

2 weeks from now

Jan 3, 2025 · FibroGen announced Q3 2024 earnings on November 12, 2024, reporting an EPS of -$0.17, which beat the consensus estimate of -$0.38 by $0.21. Quarterly revenue was …

marketbeat.com

FAQs about Fibrogen Stock Ownership - Who Owns Fibrogen in 2024? Coupon?

Who owns FibroGen?

Our data indicates that hedge funds own 5.1% of FibroGen. That worth noting, since hedge funds are often quite active investors, who may try to influence management. Many want to see value creation (and a higher share price) in the short term or medium term. The company's largest shareholder is PRIMECAP Management Company, with ownership of 14%. ...

What is the current price of FibroGen shares?

As of this writing, FibroGen shares are trading at $15.16 apiece. The stock has been up 12% over the past year and is currently above the long-term trend of the 200-day moving average line of $12.69 and above the midpoint of $13.06 of the 52-week range of $7.81 to $18.31. ...

Who is the CEO of FibroGen?

FibroGen, Inc. (NASDAQ: FGEN) announced today that Thomas B. Neff, who is the CEO and Chairman of the Board of Directors of FibroGen, passed away unexpectedly this past weekend. Board member James A. Schoeneck has been named FibroGen’s Interim CEO. ...

Is FibroGen (FibroGen) a good investment?

Despite facing strong headwinds, FibroGen, an American biotech company, has achieved a high market valuation. Is it a good investment? The company develops treatments for health problems in patients with very rare diseases. ...

Who owns FibroGen & XTX Topco?

Assenagon Asset Management S.A. acquired a new position in shares of FibroGen in the 3rd quarter valued at $307,000. XTX Topco Ltd purchased a new position in shares of FibroGen in the 2nd quarter valued at $424,000. Cubist Systematic Strategies LLC grew its position in shares of FibroGen by 3,906.9% in the 2nd quarter. ...

Should you buy FibroGen (FibroGen)?

StockNews.com began coverage on FibroGen in a research report on Wednesday, January 1st. They set a “hold” rating on the stock. HC Wainwright upgraded shares of FibroGen to a “strong-buy” rating in a research report on Tuesday, December 17th. ...